AroCell AB (publ) (AROC.ST)
SEK 0.59
(-2.33%)
SEK 0.59
(-2.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -13.43 Million | -13.69 Million | -28.2 Million | -18.9 Million | -15.05 Million | -16.4 Million |
| Net Income | -59.74 Million | -59.29 Million | -50.57 Million | -24.05 Million | -20.73 Million | -20.75 Million |
| Depreciation & Amortization | 45.53 Million | 47.18 Million | 4.79 Million | 4.59 Million | 4.53 Million | 4.21 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -374 Thousand | -1.37 Million | -2.42 Million | 557 Thousand | 1.14 Million | 131.47 Thousand |
| Other non-cash items | 1.15 Million | -200 Thousand | 19.99 Million | 4.35 Million | -452.00 | -574.00 |
| Investing Cash Flow | -1.28 Million | -10.11 Million | 4.54 Million | -53 Thousand | -244.96 Thousand | - |
| Investments in PPE | -1.27 Million | -4.05 Million | -370 Thousand | -53 Thousand | -244.96 Thousand | - |
| Acquisitions | - | -6.05 Million | 4.91 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1000.00 | -1000.00 | -370 Thousand | - | - | - |
| Financing Cash Flow | 250 Thousand | 70.59 Million | - | 47.33 Million | -803 Thousand | 28.89 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -5 Million | - | - | - | - |
| Common Stock Issuance | 250 Thousand | 86.81 Million | - | 54.42 Million | -802.82 Thousand | 34.94 Million |
| Other Financing Activities | 250 Thousand | -11.21 Million | - | -7.08 Million | -803 Thousand | -6.05 Million |
| Accounts receivables | 1.03 Million | -4.27 Million | -1.17 Million | 250 Thousand | -210.12 Thousand | 115.86 Thousand |
| Accounts payables | -1.03 Million | 4.27 Million | -1.3 Million | 244 Thousand | 1.06 Million | 69.1 Thousand |
| Inventory | -115 Thousand | -465 Thousand | 57 Thousand | 63 Thousand | 288.42 Thousand | -53.5 Thousand |
| Other working capital | -259 Thousand | -912 Thousand | -1.3 Million | 244 Thousand | 1.06 Million | 184.97 Thousand |
| Cash at beginning of period | 65.18 Million | 18.4 Million | 42.06 Million | 13.63 Million | 29.73 Million | 17.24 Million |
| Cash at end of period | 50.72 Million | 65.18 Million | 18.4 Million | 42.01 Million | 13.63 Million | 29.73 Million |
| Capital Expenditure | -1.27 Million | -4.05 Million | -370 Thousand | -53 Thousand | -244.96 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -14.46 Million | 46.78 Million | -23.66 Million | 28.38 Million | -16.1 Million | 12.48 Million |
| Free Cash Flow | -14.71 Million | -17.75 Million | -28.57 Million | -18.95 Million | -15.3 Million | -16.4 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | -13.05 Million | -10.5 Million | -59.74 Million | -17.13 Million | -13 Million |
| Depreciation & Amortization | - | - | - | 45.53 Million | 15.85 Million | 9.89 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -374 Thousand | 2.54 Million | - |
| Other non-cash items | -4.16 Million | 15.82 Million | 6.29 Million | 1.15 Million | -9.03 Million | -9.41 Million |
| Investing Cash Flow | -9000.00 | -409 Thousand | -162 Thousand | -1.28 Million | -905 Thousand | -1.15 Million |
| Investments in PPE | - | - | - | -1.27 Million | -498 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -9000.00 | -409 Thousand | -162 Thousand | -1000.00 | -407 Thousand | -1.15 Million |
| Financing Cash Flow | - | - | - | 250 Thousand | 250 Thousand | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 250 Thousand | - | - |
| Other Financing Activities | - | - | - | 250 Thousand | 250 Thousand | - |
| Accounts receivables | - | - | - | 1.03 Million | 1.03 Million | - |
| Accounts payables | - | - | - | -1.03 Million | - | - |
| Inventory | - | - | - | -115 Thousand | -115 Thousand | - |
| Other working capital | - | - | - | -259 Thousand | 1.62 Million | - |
| Cash at beginning of period | 48.7 Million | 46.34 Million | 50.72 Million | 65.18 Million | 51.51 Million | 65.18 Million |
| Cash at end of period | 44.53 Million | 48.7 Million | 46.34 Million | 50.72 Million | 50.72 Million | 51.51 Million |
| Capital Expenditure | - | - | - | -1.27 Million | -498 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | 7.64 Million | - |
| Net cash flow / Change in cash | -4.17 Million | 2.35 Million | -4.37 Million | -14.46 Million | -789 Thousand | -13.67 Million |
| Free Cash Flow | -4.16 Million | 2.76 Million | -4.21 Million | -14.71 Million | -8.27 Million | -12.52 Million |
064550
EVGIF
002821
6698
603861
FTII